81228-87-7

Basic information

• Product Name: Cyclobutyl chloroformate
• Synonyms: Cyclobutyl chloroformate;Cyclobutyl Carbonochloridate
• CAS NO: 81228-87-7
• Molecular Formula: C₅H₇ClO₂
• Molecular Weight: 134.56088
• Mol File: 81228-87-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 148.3°Cat760mmHg
• Flash Point: 56.8°C
• Appearance: /
• Density: 1.24g/cm³
• Vapor Pressure: 4.25mmHg at 25°C
• Refractive Index: 1.463
• Storage Temp.: Refrigerator, under inert atmosphere
• Solubility: Chloroform (Slightly), Methanol (Slightly)
• CAS DataBase Reference: Cyclobutyl chloroformate(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclobutyl chloroformate(81228-87-7)
• EPA Substance Registry System: Cyclobutyl chloroformate(81228-87-7)

Safety Data

• RIDADR: 2744
• HazardClass: 6.1(a)
• PackingGroup: II
• Hazardous Substances Data: 81228-87-7(Hazardous Substances Data)

Usage

Uses

Derivative of Cyclobutyl Carbonochloridate possesses antitumor activities against human non-small cell lung cancer line.

General Description

A clear liquid. Denser than water. Fire risk. Toxic and corrosive. Flash point near 70°F. Contact may severely irritate skin, eyes and mucous membranes. Toxic by ingestion, inhalation and skin absorption. Used to make other chemicals.

Air & Water Reactions

Highly flammable. Reacts with moisture in air to generate heat and hydrochloric acid fumes [Merck, 11th ed., 1989]. Decomposes exothermically in water.

Reactivity Profile

Cyclobutyl chloroformate is water reactive. Incompatible with strong oxidizing agents, alcohols, bases, including amines. May react vigorously or explosively if mixed with diisopropyl ether or other ethers in the presence of trace amounts of metal salts [J. Haz. Mat., 1981, 4, 291].

InChI:InChI=1/C5H7ClO2/c6-5(7)8-4-2-1-3-4/h4H,1-3H2

Upstream product

• 75-44-5 phosgene 
• 2919-23-5 cyclobutanol 
• 32315-10-9 bis(trichloromethyl) carbonate 

Downstream Products

• 1416137-37-5 C₂₁H₂₇FN₄O₄S 
• 125303-01-7 N-Methyl-N-phenylcyclobutylurethane 
• 70458-24-1 cyclobutyl m-chlorobenzoyl carbonate 

Relevant articles and documents

Substituted Pyrrolidines and Methods of Use

The invention discloses compounds of Formula (I) wherein R1, R2, R2A, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

3-SUBSTITUTED-6-(PYRIDINYLMETHOXY)-PYRROLOPYRIDINE COMPOUNDS

The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I).

NOVEL VINBLASTINE DERIVATIVES, THEIR PREPARATION, USE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID DERIVATIVES

The invention provides vinblastine derivatives represented by the following formula 1 or their physiologically acceptable salts, their preparation, use and pharmaceutical compositions comprising the said derivatives. The said vinblastine derivatives show inhibiting activities against tumor cell lines and can be used as medicaments for treating malignant tumors.